Screener
Eligibility screening
Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
6 US sites in CA, FL, MO, NJ +2
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.